
Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months
Keywords: تجزیه و تحلیل کوواریانس; AE; adverse event; ANCOVA; analysis of covariance; AS03; oil-in-water emulsion based Adjuvant System containing tocopherol; ATP; according to protocol; CBER; Center for Biologics Evaluation and Research; CI; confidence interval; FDA; Food and Drug Adminis